Health In Tech Inc (NASDAQ:HIT) price closed lower on current market day and dropping -25.80% below its previous close.
A look at the daily price movement shows that the last close reads $1.10, with intraday deals fluctuated between $0.7861 and $1.08. The company’s P/E ratio in the trailing 12-month period read 24.29. Taking into account the 52-week price action we note that the stock hit a 52-week high of $7.59 and 52-week low of $1.02. The stock subtracted -86.33% on its value in the past month.
Health In Tech Inc, which has a market valuation of $9.55 million, is expected to release its quarterly earnings report in April.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.
The overview shows that HIT’s price is at present -86.45% off the SMA20 and -85.75% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 18.31, with weekly volatility standing at 142.19%. The indicator jumps to 38.87% when calculated based on the past 30 days. Health In Tech Inc (NASDAQ:HIT)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.82.
An analysis of the Health In Tech Inc (NASDAQ:HIT) stock in terms of its daily trading volume indicates that the 3-month average is 1.67 million. However, this figure increases on the past 10-day timeline to an average of 4.06 million.
Current records show that the company has 42.37M in outstanding shares. The insiders’ percentage holdings are 85.58% of outstanding shares while the percentage share held by institutions stands at 0.01%. The stats also highlight that short interest as of 2025-02-28, stood at 0.12 million shares, which puts the short ratio at the time at 0.07. From this we can glean that short interest is 97.00 of company’s current outstanding shares. Notably, we see that shares short in February rose slightly given the previous month’s figure stood at 17143.0. But the -84.76% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
